EP2763992B1 - Novel Chiral N-Acyl-5,6,7,(8-Substituted)-Tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as Selective Nk-3 Receptor Antagonists, Pharmaceutical Composition, and Methods for Use in Nk-3 Receptor Mediated Disorders